Related Experiment Videos

Use of rifampin as an effective chemoprotectant and antidote against microcystin-LR toxicity

S J Hermansky1, S N Wolff, S J Stohs

  • 1School of Pharmacy and Allied Health Professions, Creighton University, Omaha, Nebr.

Pharmacology
|January 1, 1990
PubMed

Insights

Rifampin effectively protected mice from lethal microcystin-LR (MCLR) poisoning. This antibiotic acted as a crucial antidote, even when administered after exposure to the potent blue-green algae toxin.

Area of Science:

  • Environmental Toxicology
  • Pharmacology
  • Microbiology

Background:

  • Microcystin-LR (MCLR) is a toxic cyclic heptapeptide produced by Microcystis aeruginosa blooms.
  • Ingestion of MCLR-contaminated water causes frequent wildlife and domestic animal fatalities.
  • There is a critical need for effective antidotes against MCLR poisoning.

Purpose of the Study:

  • To investigate the potential of the semisynthetic antibiotic rifampin as an antidote for MCLR toxicity.
  • To evaluate the efficacy of rifampin in preventing MCLR-induced lethality in a mouse model.

Main Methods:

  • Mice were administered a lethal dose of MCLR (100 µg/kg).
  • Rifampin was administered at various doses (10-25 mg/kg) and time points (coadministration, 15, 30, or 60 min prior/post MCLR).
  • Survival rates and time to death were recorded to assess rifampin's protective effects.

Main Results:

  • Rifampin (25 mg/kg) coadministered or given 30-60 min before MCLR prevented all deaths.
  • 25 mg/kg rifampin administered 15 min after MCLR achieved 75% survival.
  • Lower doses or delayed administration showed reduced, but still significant, protective effects.

Conclusions:

  • Rifampin demonstrates significant chemoprotective and antidote capabilities against MCLR toxicity in mice.
  • Rifampin can be successfully administered post-exposure to mitigate the lethal effects of microcystin-LR.
  • These findings highlight rifampin as a promising therapeutic agent for microcystin poisoning.

Related Concept Videos